HUGEL

2025-08-11

Hugel launches botulinum toxin Letybo in Malaysia

The company strengthens brand experience for local medical professionals through academic events and hands-on workshops

2025-08-06

Hugel posts record first-half net sales exceeding KRW200 billion in H1 2025

The net sales and operating profit for Q2 hit KRW110.3 billion and KRW56.7 billion, up 15.5% and 33.6% on-year, respectively

May 13, 2025

Hugel officially launches its botulinum toxin Botulax in UAE

The company renews its momentum in the Middle East with the event where 180 dermatologists and plastic surgeons attended

May 8, 2025

Hugel posts KRW89.8 billion in net sales, marking record Q1 earnings

The company logs KRW89.8 billion in net sales, KRW39.0 billion in operating profit, and KRW30.9 billion in net profit, respectively up 20.9%, 62.6%, and 35.9% on-year

April 21, 2025

Hugel hosts seminar in Kazakhstan for launching Botulax, Revolax

Hugel introduces its botulinum toxin and dermal filler products in the Central Asian country for about 120 local medical professionals

March 31, 2025

Hugel holds 24th annual shareholders meeting

Hugel held the meeting at Sejong Hotel in Chuncheon on March 31, approving six resolutions including 2024 financial statements and appointment of board directors and audit committee members

March 14, 2025

Hugel appoints Chulmin Park as Representative Executive Officer

Park begins his term, alongside the current Representative Executive Officer Hyoungjin Moon

February 13, 2025

Hugel achieves record net sales, profit, net income in 2024

The company reports KRW373.0 billion in net sales, KRW166.3 billion in operating profit, and KRW142.4 billion in net income, reflecting year-over-year increases of 16.7%, 41.2%, and 45.8%, respectively

January 22, 2025

Hugel wins UAE approval for botulinum toxin Botulax

The 50IU, 100IU and 200IU formulations cover aesthetic and therapeutic indications l The strong partnership with Medica Group will boost Hugel’s expansion in the MENA

January 17, 2025

Hugel vows to become global leader at J.P. Morgan Healthcare Conference

Hugel CFO Eva Huang presents mid- to long-term growth strategy at the APAC Track l The medical aesthetics company aims to expand its presence in more than 80 toxin markets, 70 dermal filler markets, and more than 10 cosmetics markets by 2028

News

点击查看飞速发展的HUGEL最新消息。